BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08103402 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08103402\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07660731-4338@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20270330
DTEND;VALUE=DATE:20270331
SUMMARY:PF-08103402: Phase 1 readout est. (NCT07660731)
DESCRIPTION:PF-08103402\, phase 1\, Asthma.\nStudy: A Study to Learn How Di
 fferent Amounts of the Study Medicine Called PF-08103402 Are Tolerated and
  Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma\
 nEstimated primary completion: 30 March 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/pf-08103402#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT07660731
URL:https://assetmemo.bio/drug/pf-08103402#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
